Jiabo Li

Summary

Affiliation: Accelrys Inc
Country: USA

Publications

  1. ncbi Bioactive conformational generation of small molecules: a comparative analysis between force-field and multiple empirical criteria based methods
    Fang Bai
    Department of Engineering Mechanics, State Key Laboratory of Structural Analysis for Industrial Equipment, Dalian University of Technology, Dalian 116023, PR China
    BMC Bioinformatics 11:545. 2010
  2. ncbi CAESAR: a new conformer generation algorithm based on recursive buildup and local rotational symmetry consideration
    Jiabo Li
    Accelrys Inc, 10188 Telesis Court, San Diego, California 92121, USA
    J Chem Inf Model 47:1923-32. 2007
  3. ncbi New features that improve the pharmacophore tools from Accelrys
    Jon Sutter
    Accelrys, Inc, San Diego, CA 92121, USA
    Curr Comput Aided Drug Des 7:173-80. 2011

Collaborators

  • Jon Sutter
  • Fang Bai
  • Xiaofeng Liu
  • Hualiang Jiang
  • Haoyun Zhang
  • Honglin Li
  • Xicheng Wang

Detail Information

Publications3

  1. ncbi Bioactive conformational generation of small molecules: a comparative analysis between force-field and multiple empirical criteria based methods
    Fang Bai
    Department of Engineering Mechanics, State Key Laboratory of Structural Analysis for Industrial Equipment, Dalian University of Technology, Dalian 116023, PR China
    BMC Bioinformatics 11:545. 2010
    ....
  2. ncbi CAESAR: a new conformer generation algorithm based on recursive buildup and local rotational symmetry consideration
    Jiabo Li
    Accelrys Inc, 10188 Telesis Court, San Diego, California 92121, USA
    J Chem Inf Model 47:1923-32. 2007
    ..In addition, it is shown that CEASAR covers the pharmacophore space as well or better than Catalyst/FAST...
  3. ncbi New features that improve the pharmacophore tools from Accelrys
    Jon Sutter
    Accelrys, Inc, San Diego, CA 92121, USA
    Curr Comput Aided Drug Des 7:173-80. 2011
    ..Recently we also developed new pharmacophore tools in the area of structure based design - deriving pharmacophores from the receptor as well as the receptor-ligand complex - which will also be discussed in this paper...